Company Abpro Holdings, Inc.

Equities

ABPO

US0008472021

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 18:51:08 16/03/2026 GMT			5-day change	1st Jan Change
0.1180 ^USD	-3.28%		+18.00%	-97.21%

02-25	Abpro Holdings, Inc.(NasdaqCM:ABP) dropped from S&P TMI Index	CI
02-19	Abpro Holdings, Inc.(OTCPK:ABPO) dropped from NASDAQ Composite Index	CI

Business description: Abpro Holdings, Inc.

Abpro Holdings, Inc. is a biotechnology company dedicated to developing next-generation antibody therapeutics, which helps in improving the lives of patients with severe and life-threatening diseases. The Company is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its DiversImmune and MultiMab antibody discovery and engineering platforms, it is engaged in developing a pipeline of antibodies, both independently and through collaborations with global pharmaceutical and research institutions. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patientâ€™s immune system to fight cancer by engaging T cells through co-targeting human epidermal growth factor receptor 2 (HER2), and cluster of differentiation 3 (CD3), T-cell co-receptor.

Number of employees: 11

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ABPRO HOLDINGS, INC.	-3.28%	+18.00%	-99.21%	-99.96%	331K
LONZA GROUP AG	+0.27%	-3.29%	-13.88%	-10.15%	42.78B
BEONE MEDICINES AG	+1.97%	-4.18%	+9.27%	+28.87%	31.5B
CELLTRION, INC.	-2.68%	-5.88%	+11.77%	+44.44%	29.99B
IQVIA HOLDINGS INC.	+0.10%	-7.65%	-10.82%	-16.06%	27.65B
REVOLUTION MEDICINES, INC.	+4.36%	-0.79%	+153.00%	+345.14%	18.8B
ASCENDIS PHARMA A/S	+2.23%	-3.71%	+36.83%	+110.62%	13.87B
MEDPACE HOLDINGS, INC.	+0.72%	-5.20%	+39.01%	+148.90%	12.78B
EUROFINS SCIENTIFIC SE	-0.33%	-3.53%	+22.17%	-0.65%	12.39B
IONIS PHARMACEUTICALS, INC.	+1.62%	-4.01%	+110.90%	+106.69%	11.76B
Average	+0.53%	-1.46%	+25.91%	+65.78%	20.15B
Weighted average by Cap.	+0.72%	-4.61%	+25.89%	+62.21%